Options: Hide MedDRA Preferred Terms
MedDRA Preferred Term | Side effect | Data for drug | Placebo | Labels | |
---|---|---|---|---|---|
1 | 2 | ||||
Cyanosis | Cyanosis | x | |||
Dermatitis contact | Dermatitis contact | x | |||
Dyspnoea | Dyspnoea | x | |||
Oedema | Oedema | x | |||
Dermatitis | Rash | x | x | ||
Rash | Rash | x | x | ||
Hypersensitivity | Hypersensitivity | x | x | ||
Methaemoglobinaemia | Methaemoglobinaemia | x | |||
Pruritus | Pruritus | x | x | ||
Swelling | Swelling | x | |||
Erythema | Erythema | x | |||
Redness | x | ||||
Urticaria | Urticaria | x | x | ||
Tenderness | Tenderness | x | |||
Respiratory distress | Respiratory distress | x | |||
Oral discomfort | Burning mouth | x |
Information about indications was extracted from the indications and usage sections of the labels.
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |